The Edwards Lifesciences Fund to Grant ~$5.6 Million to 450+ Non-Profit
Organizations in 2013
IRVINE, CA -- (Marketwired) -- 12/06/13 -- Edwards Lifesciences
Corporation (NYSE: EW), the global leader in the science of heart
valves and hemodynamic monitoring, announced today that The Edwards
Lifesciences Fund will grant approximately $5.6 million this year to
support health- and community-focused charitable initiatives. Gifts
will be distributed to more than 450 non-profit organizations around
the world, including 200 supported through the company's Employee
Matching Gift Program. Grant recipients were recognized earlier in
the week at an annual awards celebration held at Edwards' corporate
headquarters in Irvine. Since its inception in 2004, the Fund has
gifted more than $30 million to non-profit organizations.
"Our employees share our passion for giving and often contribute
their own time to the organizations that we support through our
Fund," said Michael A. Mussallem, Edwards Lifesciences' chairman and
CEO. "Collectively, we are honored to share our success with these
organizations and the many people they touch."
About Edwards Lifesciences and The Edwards Lifesciences Fund
Lifesciences is the global leader in the science of heart valves and
hemodynamic monitoring. Driven by a passion to help patients, the
company partners with clinicians to develop innovative technologies
in the areas of structural heart disease and critical care
monitoring, enabling them to save and enhance lives. In 2004, the
company established The Edwards Lifesciences Fund at the Vanguard
Charitable Endowment Program to support advancements in knowledge and
improvements in quality-of-life, focusing primarily upon
cardiovascular disease and the communities where its employees live
and work. The Fund's mission is fulfilled by making grants to
qualified charitable organizations. Additional information about the
company and its Fund can be found at www.edwards.com.
Edwards, Edwards Lifesciences and the stylized E logo are trademarks
of Edwards Lifesciences Corporation.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2474676
Amanda C. Fowler
David K. Erickson
Press spacebar to pause and continue. Press esc to stop.